Shinobi Therapeutics

0 followers

‌

Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.

Industries

Biotechnology, Life Sciences

Headquarters

South San Francisco, US

Employees

11-50

Links

Org chart

Dan Kemp

Chief Executive Officer

Dan Kemp

Collapse

Bhanu Iyer

VP US Operations & HR

Ryosuke Gonotsubo

Chief Of Staff

Teams

This company has no teams yet

Similar companies

Vaxcyte

2 followers

89bio

2 followers

Apogee Therapeutics

1 follower

Alveo Technologies

1 follower

QbDVision

1 follower

Revvity

4 followers

Thermo Fisher Scientific

165 followers

Exact Sciences

15 followers

CRISPR Therapeutics

10 followers

Pfizer

483 followers

United Therapeutics

7 followers

Explore companies